Roles of Organic Anion Transporters in the Renal Excretion of Perfluorooctanoic Acid
Hatsuki Nakagawa
Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto,
Search for more papers by this authorTaku Hirata
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, and
Search for more papers by this authorTomohiro Terada
Department of Pharmacy, Kyoto University Hospital, Kyoto, Japan
Search for more papers by this authorPromsuk Jutabha
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, and
Search for more papers by this authorDaisaku Miura
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, and
Search for more papers by this authorKouji H. Harada
Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto,
Search for more papers by this authorKayoko Inoue
Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto,
Search for more papers by this authorNaohiko Anzai
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, and
Search for more papers by this authorHitoshi Endou
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, and
Search for more papers by this authorKen-ichi Inui
Department of Pharmacy, Kyoto University Hospital, Kyoto, Japan
Search for more papers by this authorYoshikatsu Kanai
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, and
Search for more papers by this authorAkio Koizumi
Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto,
Search for more papers by this authorHatsuki Nakagawa
Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto,
Search for more papers by this authorTaku Hirata
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, and
Search for more papers by this authorTomohiro Terada
Department of Pharmacy, Kyoto University Hospital, Kyoto, Japan
Search for more papers by this authorPromsuk Jutabha
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, and
Search for more papers by this authorDaisaku Miura
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, and
Search for more papers by this authorKouji H. Harada
Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto,
Search for more papers by this authorKayoko Inoue
Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto,
Search for more papers by this authorNaohiko Anzai
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, and
Search for more papers by this authorHitoshi Endou
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, and
Search for more papers by this authorKen-ichi Inui
Department of Pharmacy, Kyoto University Hospital, Kyoto, Japan
Search for more papers by this authorYoshikatsu Kanai
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, and
Search for more papers by this authorAkio Koizumi
Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto,
Search for more papers by this authorAbstract
Abstract: Perfluorooctanoic acid, an environmental contaminant, is found in both wild animals and human beings. There are large species and sex differences in the renal excretion of perfluorooctanoic acid. In the present study, we aimed to characterize organic anion transporters 1–3 (OAT1–3) in human beings and rats to investigate whether the species differences in the elimination kinetics of perfluorooctanoic acid from the kidneys can be attributed to differences in the affinities of these transporters for perfluorooctanoic acid. We used human (h) and rat (r) OAT transient expression cell systems and measured the [14C] perfluorooctanoic acid transport activities. Both human and rat OAT1 and OAT3 mediated perfluorooctanoic acid transport to similar degrees. Specifically, the kinetic parameters, Km, were 48.0 ± 6.4 µM for h OAT1; 51.0 ± 12.0 µM for rOAT1; 49.1 ± 21.4 µM for hOAT3 and 80.2 ± 17.8 µM for rOAT3, respectively. These data indicate that both human and rat OAT1 and OAT3 have high affinities for perfluorooctanoic acid and that the species differences in its renal elimination are not attributable to affinity differences in these OATs between human beings and rats. In contrast, neither hOAT2 nor rOAT2 transported perfluorooctanoic acid. In conclusion, OAT1 and OAT3 mediated perfluorooctanoic acid transport in vitro, suggesting that these transporters also transport perfluorooctanoic acid through the basolateral membrane of proximal tubular cells in vivo in both human beings and rats. Neither human nor rat OAT2 mediated perfluorooctanoic acid transport. Collectively, the difference between the perfluorooctanoic acid half-lives in human beings and rats is not likely to be attributable to differences in the affinities of these transporters for perfluorooctanoic acid.
References
- 1 Kissa E. Fluorinated Surfactants and Repellents, 2nd ed. Marcel Dekker, New York, 2001.
- 2 Office of Pollution Prevention and Toxics. Preliminary Risk Assessment of the Developmental Toxicity Associated with Exposure to Perfluorooctanoic Acid and Its Salts. U.S. Environmental Protection Agency, Washington, DC, 2003.
- 3 Abdellatif AG, Preat V, Taper HS, Roberfroid M. The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator. Toxicol Appl Pharmacol 1991; 111: 530–7.
- 4 Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 2006; 90: 510–8.
- 5 Sohlenius AK, Lundgren B, DePierre JW. Perfluorooctanoic acid has persistent effects on peroxisome proliferation and related parameters in mouse liver. J Biochem Toxicol 1992; 7: 205–12.
- 6 Intrasuksri U, Rangwala SM, O’Brien M, Noonan DJ, Feller DR. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids. Gen Pharmacol 1998; 31: 187–97.
- 7
Upham BL,
Deocampo ND,
Wurl B,
Trosko JE.
Inhibition of gap junctional intercellular communication by perfluorinated fatty acids is dependent on the chain length of the fluorinated tail.
Int J Cancer
1998; 78: 491–5.
10.1002/(SICI)1097-0215(19981109)78:4<491::AID-IJC16>3.0.CO;2-9 CAS PubMed Web of Science® Google Scholar
- 8 Yang Q, Abedi-Valugerdi M, Xie Y, Zhao XY, Möller G, Nelson BD et al. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int Immunopharmacol 2002; 2: 389–97.
- 9 Harada K, Xu F, Ono K, Iijima T, Koizumi A. Effects of PFOS and PFOA on L-type Ca2+ currents in guinea-pig ventricular myocytes. Biochem Biophys Res Commun 2005; 329: 487–94.
- 10 Matsubara E, Harada K, Inoue K, Koizumi A. Effects of perfluorinated amphiphiles on backward swimming in Paramecium caudatum. Biochem Biophys Res Commun 2006; 339: 554–61.
- 11 Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexansulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Persp 2007; 115: 1298–1305.
- 12 Kudo N, Katakura M, Sato Y, Kawashima Y. Sex hormone-regulated renal transport of perfluorooctanoic acid. Chem Biol Interact 2002; 139: 301–16.
- 13 Kudo N, Kawashima Y. The Study of Excretion Pathway and Long-Term Persistency of Fluorinated Fatty Acids in Primates. Annual Reports of the Primate Research Institute, Kyoto University, Inuyama, Aichi, 2001.
- 14 Butenhoff J, Costa G, Elcombe C, Farrar D, Hansen K, Iwai H et al. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol Sci 2002; 69: 244–57.
- 15 Vanden Heuvel JP, Kuslikis BI, Van Rafelghem MJ, Peterson RE. Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. J Biochem Toxicol 1991; 6: 83–92.
- 16 Buist SC, Cherrington NJ, Choudhuri S, Hartley DP, Klaassen CD. Gender-specific and developmental influences on the expression of rat organic anion transporters. J Pharmacol Exp Ther 2002; 301: 145–51.
- 17 Ljubojevic M, Balen D, Breljak D, Kusan M, Anzai N, Bahn A et al. Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones. Am J Physiol Renal Physiol 2007; 292: F361–72.
- 18 Harada K, Inoue K, Morikawa A, Yoshinaga T, Saito N, Koizumi A. Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res 2005; 99: 253–61.
- 19 Cha SH, Sekine T, Fukushima JI, Kanai Y, Kobayashi Y, Goya T et al. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 2001; 59: 1277–86.
- 20 Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 1997; 272: 18526–9.
- 21 Enomoto A, Takeda M, Shimoda M, Narikawa S, Kobayashi Y, Kobayashi Y et al. Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther 2002; 301: 797–802.
- 22 Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH et al. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 1999; 274: 13675–80.
- 23 Hosoyamada M, Sekine T, Kanai Y, Endou H. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol 1999; 276: F122–8.
- 24 Takeda M, Tojo A, Sekine T, Hosoyamada M, Kanai Y, Endou H. Role of organic anion transporter 1 (OAT1) in cephaloridine (CER)-induced nephrotoxicity. Kidney Int 1999; 56: 2128–36.
- 25 Sweet DH, Wolff NA, Pritchard JB. Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney. J Biol Chem 1997; 272: 30088–95.
- 26 Sweet DH, Miller DS, Pritchard JB, Fujiwara Y, Beier DR, Nigam SK. Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J Biol Chem 2002; 277: 26934–43.
- 27 Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M et al. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol 2002; 13: 866–74.
- 28 Andersen ME, Clewell HJ 3rd, Tan YM, Butenhoff JL, Olsen GW. Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys–probing the determinants of long plasma half-lives. Toxicology 2006; 227: 156–64.
- 29 Gotoh Y, Kato Y, Stieger B, Meier PJ, Sugiyama Y. Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-D-glucuronide in rats. Am J Physiol Endocrinol Metab 2002; 282: E1245–54.
- 30 Kato Y, Kuge K, Kusuhara H, Meier PJ, Sugiyama Y. Gender difference in the urinary excretion of organic anions in rats. J Pharmacol Exp Ther 2002; 302: 483–9.
- 31 Ekaratanawong S, Anzai N, Jutabha P, Miyazaki H, Noshiro R, Takeda M et al. Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci 2004; 94: 297–304.
- 32 Anzai N, Kanai Y, Endou H. Organic anion transporter family: current knowledge. J Pharmacol Sci 2006; 100: 411–26.
- 33 Johnson JD, Gibson SJ, Ober RE. Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate. Fundam Appl Toxicol 1984; 4: 972–6.
- 34 Harada KH, Hashida S, Kaneko T, Takenaka K, Minata M, Inoue K et al. Biliary excretion and cerebrospinal fluid partition of perfluorooctanoate and perfluorooctane sulfonate in humans. Environ Toxicol Pharmacol 2007; 24: 134–9.